浙江福瑞喜药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Budesonide Suspension for Inhalation
- Product Name
- 吸入用布地奈德混悬液
- Approval Number
- 国药准字H20244983
- Approval Date
- Sep 26, 2024
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20213544
- Approval Date
- Jun 22, 2021
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20213545
- Approval Date
- Jun 22, 2021
NMPA
Compound Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用复方异丙托溴铵溶液
- Approval Number
- 国药准字H20213543
- Approval Date
- Jun 22, 2021
NMPA
Salbutamol Sulfate Solution for Inhalation
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20213118
- Approval Date
- Feb 2, 2021
NMPA
Clinical Trials
No trials found
News
No news found